Navigation Links
AMA Adopts New Policies at Annual Meeting
Date:6/17/2008

CHICAGO, June 17 /PRNewswire-USNewswire/ -- The American Medical Association (AMA), the nation's largest physician group, voted today at its Annual Meeting to adopt the following new policies.

APPROPRIATE ASPIRIN USE FOR PREVENTION OF HEART DISEASE AND STROKE: Six trials, involving more than 95,000 adult men and women, have shown aspirin may be effective in reducing the risk of heart attack and stroke. The AMA today passed policy to increase education among physicians on the importance of appropriate aspirin counseling for the prevention of heart disease and stroke.

"Heart disease continues to be the number one cause of death in the United States, and the treatment of cardiovascular disease costs the health care system $403 billion a year," said AMA Board Member William Hazel, M.D. "Encouraging physicians to incorporate aspirin counseling into patient care when appropriate, may help reduce the prevalence of heart disease and stroke among Americans."

CANCER AND HEALTH CARE DISPARITIES AMONG MINORITY WOMEN: According to the National Cancer Institute, minority women have a significantly higher cancer mortality rate than Caucasian women. In an effort to combat this troubling fact, the AMA adopted new policy urging more research and funding to address the racial and ethnic disparities in cancer screening, diagnosis, and treatment among minority women.

"There continues to be great disparities in the detection and treatment of cancer among minority women," said AMA Board Member Samantha Rosman, M.D. "Physicians must work to promote cancer education to their minority patients in a way that is understandable and culturally sensitive."

RACIAL AND ETHNIC DISPARITIES IN MATERNAL MORTALITY:

The Centers for Disease Control and Prevention report that maternal mortality rates in the U.S. are at the highest in decades, with the maternal mortality rate among African American women being especially high. Today the AMA voted to support increased efforts to educate providers, hospitals and patient organizations about the increasing risk of maternal mortality in the U.S. and the importance of preconception care, and urged further study of racial disparities in maternal mortality.

"Along with obesity and hypertension, racial disparities has been identified as the most significant factor contributing to the high maternal mortality rate," said AMA Board Member Samantha Rosman, M.D. "More studies need to be done to better understand this disturbing trend in maternal mortality and to determine what can be done to correct it."

DIRECT-TO-CONSUMER ADVERTISING AND PROVISION OF GENETIC TESTING: More than 1400 genetic tests are available for purchase directly from consumers, without a prescription or any involvement from a health care professional. A new set of policy recommendations were adopted today to protect patients who may use a direct-to-consumer genetic test. Among the recommendations are, that genetic testing be carried out under the supervision of a qualified health care professional, that appropriate organizations be encouraged to develop criteria for the advertising of DTC genetic tests, and that physicians are provided with more information on the types of genetic tests available so that patients can be appropriately counseled on the potential harms.

"The availability of direct-to-consumer genetic tests is increasing as advances in genetic research reveal the association between genes and disease," said AMA Board Member William Hazel, M.D. "Encouraging all genetic testing to require supervision by a qualified health care professional, ensures they are being properly used and the results are being accurately interpreted and understood by patients."


'/>"/>
SOURCE American Medical Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. SyntheMed, Inc. Adopts Shareholder Rights Plan
2. Haemonetics Chairman and CEO Adopts 10b5-1 Stock Trading Plan
3. Virginias largest Cardiac Surgery program adopts SPY as standard of care
4. Edwards Lifesciences Chairman and CEO Adopts New 10b5-1 Stock Trading Plan to Replace Recently Expired Plan
5. Indiana Adopts Legislation to Combat Illegitimate Online Pharmacies, Protect Residents From Counterfeit Drugs
6. Weight Watchers COO Adopts 10b5-1 Trading Plan
7. Masimo Corporation Adopts Stockholder Rights Plan
8. APHA Adopts New Policies on Food Safety, Global Climate Change, Multidrug-Resistant Organisms, Breastfeeding and Feminine Hygiene
9. Texas Health and Human Services Commission Adopts Mediwares ClosedLoop(TM) Medication Management Strategy
10. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
11. Aionex Adopts SkyeTeks Embedded RFID Solution to Ensure Patient Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... In 2009, Carol Bryan ... resulted in severe facial disfiguration. After four frightening years of isolation and emotional ... Medical Center, who removed the substances in a partial facial transplant through eight ...
(Date:1/19/2017)... ... January 19, 2017 , ... Workrite Ergonomics announced this ... The Tranquility privacy panel system was designed to deliver the ideal blend of ... noise and provide the visual privacy required to maintain concentration levels and increase ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... Sam ... planning assistance to commercial and residential clients in the California Bay Area, is launching ... heart health in the region. , Heart disease is the primary killer of adult ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... which serves Lawrenceville, New Jersey and the surrounding area, is inaugurating a ... sclerosis (ALS), more commonly known as Lou Gehrig's disease or motor neurone disease, ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Spring Create Real Impact contest from Impact Teen Drivers and California Casualty. Entries ... . , Educational grants totaling $15,000 will be awarded for the best ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... , January 19, 2017 According to a ... cryotherapy is set to witness a CAGR of 6.5% during the ... will continue to be the leading market for cryotherapy ... ... are emphasizing on ensuring affordable and adequate supply of gas in ...
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... blood analysis instruments and consumables for the medical and ... discuss its financial results for the third quarter fiscal ... be at 4:15 p.m. ET on Thursday, January 26, ... third quarter fiscal year 2017 after the market closes ...
Breaking Medicine Technology: